Overview
Regional activity, market composition and current signals.
Gulf longevity and HealthTech intelligence
Gulf HealthTech & Longevity
Investment Analytics
A specialist intelligence platform for understanding the companies, technologies, investors and market opportunities driving the Gulf’s longevity and HealthTech economy.
Verified regional coverage
Connected market relationships
Decision-ready analysis
Regional market intelligence
A clearer way to understand where the Gulf HealthTech market is moving
The platform brings companies, investors, transactions, partnerships and government activity into one structured regional view — with the local detail required to understand each market properly.
Instead of working across disconnected lists, reports and announcements, users can follow the relationships behind market activity: where capital is moving, which organisations are gaining momentum, how sectors are developing and where credible opportunities may emerge next.
Screen investment opportunities
Prepare market-entry decisions
Identify strategic partners
Build decision-ready briefings
Intelligence coverage
One platform for the full regional ecosystem
Move from a Gulf-wide market view to a precise research question using country, sector, stage, date, investor type and transaction filters — while preserving the relationships between every result.
Companies
Structured profiles, sectors, stages, locations and operating status.
Investors
Focus areas, portfolios and transaction activity.
Deals
Funding, M&A, licensing and other relevant transaction records.
Partnerships
Commercial, clinical, technology and institutional collaborations.
Government tracker
Programmes, initiatives, institutions and policy activity.
From source data to decision intelligence
Built for evidence that can be trusted and maintained
A disciplined data architecture converts regional sources into professional intelligence that can support investment committees, market-entry analysis, partnership development and executive briefings.
Capture
Integrate regional, national and sector-specific sources.
Verify
Apply staging, review, provenance and audit controls.
Connect
Link companies, investors, deals, partnerships and policy.
Activate
Turn verified relationships into screening and strategy.
A compounding data asset
Why the platform becomes more valuable over time
The advantage is not the size of a static database. It is the growing network of verified relationships, local sources, specialised classification and institutional use cases built on one consistent Gulf-wide model.
Specialised taxonomy
Domain-specific HealthTech and longevity classification.
Local-source integration
Country-level evidence normalised within one model.
Verification workflow
Quality control built into the architecture.
Compounding data asset
Every connection adds context and utility.
Product infrastructure
Subscriptions, exports, enterprise access and future API delivery.
Institutional relevance
One evidence base for investors, corporates and public stakeholders.
Accessible commercial model
Choose the level of intelligence your work requires
The free tier removes the traditional enterprise barrier. Paid plans then add the depth, analytics, export and institutional capabilities required for recurring professional use.
10 searches per month · basic profiles · 30-day data delay
ExplorationUnlimited search · full profiles · real-time data · export · alerts
Individual useAdvanced analytics · investor tracking · deal flow · sector reports
Professional teamsAPI access · team seats · custom filters · white-label option
InstitutionsAnnual prices reflect the 20% discount. Multi-seat, multi-year, API and government arrangements can be structured around institutional requirements.
Project materials
Review the proposition in the format you need
Start with the concise project overview, continue to the commercial opportunity, or open the complete deck for the full product, market and business case.
Strategic proposition
Build decisions on a regional evidence base that improves over time
Explore the platform or discuss subscriptions, commissioned research, data partnerships, API access and institutional licensing.